跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mycobacterium tuberculosis antigen
首页
药物
Mycobacterium tuberculosis antigen
Mycobacterium tuberculosis antigen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Desaturase antigen of mycobacterium tuberculosis
US 7071320 B2
申请人: PASTEUR INSTITUT
优先权: 2000
US
6 件公开
NANOPARTICLE VACCINE FOR PREVENTING MYCOBACTERIUM TUBERCULOSIS INFECTION AND PREPARATION METHOD THEREFOR
EP 4803097 A1
申请人: YANTAI PATRONUS BIOTECH CO LTD
优先权: 2023
CN
EP
WO
4 件公开
INTRANASAL SPRAY-TYPE TUBERCULOSIS VACCINE USING PARAMYXOVIRUS VECTOR
US 2012219582 A1
申请人: YASUTOMI YASUHIRO
优先权: 2009
CN
EP
US
3 件公开
M.tuberculosis vaccines
US 10004793 B2
申请人: STATENS SERUMINSTITUT
优先权: 2014
CN
US
2 件公开
MRNA TUBERCULOSIS VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF
WO 2026037380 A1
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
WO
2 件公开
WO 2026037381 A1
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
WO
2 件公开
TUBERCULOSIS MRNA VACCINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
WO 2026037379 A1
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
WO
2 件公开
WO 2026037383 A1
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
WO
2 件公开
MRNA PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TUBERCULOSIS AND USE THEREOF
WO 2026108989 A1
申请人: SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
WO
2 件公开
WO 2026109000 A1
申请人: SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
WO
2 件公开
WO 2026108990 A1
申请人: SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD
优先权: 2024
WO
WO 2026145659 A1
申请人: SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD
优先权: 2024
WO
PROTECTIVE ANTIGEN COMBINATION OF MYCOBACTERIUM TUBERCULOSIS AND USE THEREOF
WO 2026114342 A1
申请人: SHANGHAI INST OF INFECTIOUS DISEASE AND BIOSECURITY
优先权: 2024
CN
WO
2 件公开
Mycobacterium tuberculosis porins and toxins and related methods
US 10017550 B2
申请人: NIEDERWEIS MICHAEL
优先权: 2012
US
2 件公开
Compositions useful in the diagnostic of latently infected Mycobacterium tuberculosis
US 10067147 B2
申请人: CENTRE NAT RECH SCIENT
优先权: 2014
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈